SCHEMBL2014030

SCHEMBL2014030

CC1=NN=C(C)C1(c1cnc2[nH]cc(C(=O)c3c(F)ccc(NS(=O)(=O)c4cccc(F)c4)c3F)c2c1)S(=O)(=O)c1cn(C)nc1C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 8/20 0.65
CYP2C19 P33261 7/20 0.53
CYP2C9 P11712 7/20 0.52
CYP2D6 P10635 1/20 0.48
BRAF P15056 3/20 0.45
RIPK2 O43353 2/20 0.45
RAF1 P04049 2/20 0.45
KDR P35968 2/20 0.45
MAP2K2 P36507 2/20 0.45
TGFBR2 P37173 2/20 0.45
NEK2 P51955 2/20 0.45
MAP2K1 Q02750 2/20 0.45
TNK2 Q07912 2/20 0.45
MAP2K5 Q13163 2/20 0.45
PTK6 Q13882 2/20 0.45
NEK11 Q8NG66 2/20 0.45
MAP3K20 Q9NYL2 2/20 0.45
MAP4K5 Q9Y4K4 2/20 0.45
BMPR1B O00238 1/20 0.45
PLK4 O00444 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2014028 0.82 CYP3A4 (0.65) CYP3A4CYP2C19CYP2C9CYP2D6BRAF
SCHEMBL295554 0.80 CYP3A4 (1.00) CYP3A4CYP2C19CYP2C9CYP2D6BRAF
SCHEMBL297741 0.79 CYP3A4 (0.74) CYP3A4CYP2C19CYP2C9CYP2D6BRAF
SCHEMBL2163433 0.79 CYP3A4 (0.74) CYP3A4CYP2C19CYP2C9CYP2D6BRAF
SCHEMBL2163030 0.79 CYP3A4 (0.69) CYP3A4CYP2C19CYP2C9CYP2D6BRAF
SCHEMBL414836 0.78 CYP3A4 (0.81) CYP3A4CYP2C19CYP2C9CYP2D6BRAF
SCHEMBL2162971 0.78 CYP3A4 (0.68) CYP3A4CYP2C19CYP2C9CYP2D6BRAF
SCHEMBL2054297 0.78 CYP3A4 (0.68) CYP3A4CYP2C19CYP2C9CYP2D6BRAF
SCHEMBL410805 0.78 CYP3A4 (0.84) CYP3A4CYP2C19CYP2C9CYP2D6BRAF
SCHEMBL2162674 0.78 CYP3A4 (0.83) CYP3A4CYP2C19CYP2C9CYP2D6BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2516438-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR Plexxikon, Inc. (US) 2012-10-31 EP disclosed
WO-2011079133-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON, INC. (US) 2011-06-30 WO disclosed